What Investors ShouldKnow About Juno Therapeutics’ Recent Trial Stop and Restart

0
283

By Motley Fool Staff After two patient deaths occurred in a clinical trial of Juno Therapeutics ‘ (NASDAQ: JUNO) most advanced drug, the FDA …read more

Source:: FOX BUSINESS NEWS